Home
Conditions
Lymphoma, Non-Hodgkin

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

1,630 public trials 214 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Recruiting

MEN1703 (SEL24) to Treat Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma (JASPIS-01)

NCT06534437

Conditions: Aberrant Motor Behavior in Dementia, Aggression, Behavior, +16 more
Locations: Centre Hospitalier Le Mans Le Mans, France

CHU de Lille - Hôpital Claude Huriez Lille, France

CHU de Limoges - CHU Dupuytren Limoges, France

Hospices Civils De Lyon - Hôpital Lyon Sud Lyon, France

View all 36 locations

View Trial Details

Recruiting

Linperlisib Combination With Cyclophosphamide, Prednisone, and Thalidomide (CPT) in R/R NHL

NCT07195799

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Recruiting

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

NCT06398457

Conditions: Acute Lymphoblastic Leukemia (ALL), Adult, Acute Myeloid Leukemia (AML), Anemia, +45 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Recruiting

Evaluate Safety of Axicabtagene Ciloleucel Reinfusion (Axi-Cel-2) in Patients With Relapsed and/or Refractory Second Line High-Risk Non-Hodgkin Lymphoma After Standard of Care Axi-Cel

NCT05794958

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Stanford University Palo Alto, California, United States

View Trial Details

Recruiting

Safety Study of CC312 in Adult Patients With Relapsed/Refractory CD19 Positive B-cell Hematologic Malignancies

NCT06037018

Conditions: Acute Lymphoblastic Leukaemia, Chronic Disease, Chronic Lymphocytic Leukemia, +19 more
Locations: InstituteHBDH Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Evaluation of the Role of Connected Scales in the Therapeutic Care of Hematology Patients

NCT06133426

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: Cochin Hospital Paris, France

View Trial Details

Recruiting

A Study Investigating the Change in Metabolism Phenotype in Paediatric, Adolescent & Young Adults With Hodgkin or Non-Hodgkin Lymphoma.

NCT06383338

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +9 more
Locations: Peter MacCallum Cancer Centre Melbourne, Victoria, Australia

View Trial Details

Recruiting

Cord Blood Transplant in Adults With Blood Cancers

NCT05884333

Conditions: Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Bone Marrow Diseases, +26 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Recruiting

Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies

NCT07016165

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloblastic Leukemia, Agranulocytosis, +22 more
Locations: RSUP dr Sardjito Sleman, DI Yogyakarta, Indonesia

View Trial Details

Recruiting

A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed or Refractory B Cell Non-Hodgkin Lymphoma(NHL)

NCT06446128

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Mengchao Cancer Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Lymphoma, Non-Hodgkin

Lymphoma, Non-Hodgkin trial results

Related conditions